The critical need for guidance in managing glycaemic control in patients with cancer
- PMID: 34133784
- DOI: 10.1111/dme.14624
The critical need for guidance in managing glycaemic control in patients with cancer
Keywords: cancer; cancer immunotherapy; diabetes mellitus; glucocorticoids; hyperglycaemia; hyperinsulinaemia; tyrosine kinase inhibitors.
Comment on
-
A guideline for the outpatient management of glycaemic control in people with cancer.Diabet Med. 2022 Jan;39(1):e14636. doi: 10.1111/dme.14636. Epub 2021 Jul 16. Diabet Med. 2022. PMID: 34240470 Review.
References
REFERENCES
-
- Joharatnam-Hogan N, Chambers P, Dhatariya K, Board R, on behalf of the Joint British Society for Inpatient Care (JBDS), & UK Chemotherapy Board (UKCB). A guideline for the outpatient management of glycaemic control in people with cancer. Diabet Med. 2021:e14636.
-
- Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: a consensus report. Diabetes Care. 2010;33(7):1674-1685.
-
- Yuan C, Babic A, Khalaf N, et al. Diabetes, weight change, and pancreatic cancer risk. JAMA Oncol. 2020;6(10):e202948.
-
- Barua R, Templeton AJ, Seruga B, Ocana A, Amir E, Ethier J-L. Hyperglycaemia and survival in solid tumours: a systematic review and meta-analysis. Clin Oncol (R Coll Radiol). 2018;30(4):215-224.
-
- Barone BB, Yeh H-C, Snyder CF, et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA. 2008;300(23):2754-2764.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
